Warfarin
What's New
Last Posted: Mar 12, 2024
- Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?
Benjamin Cross et al. Pharmacogenomics J 2024 3 (2) 7 - Use of drugs with pharmacogenomics (PGx)-based dosing guidelines in a Danish cohort of persons with chronic kidney disease, both on dialysis and not on dialysis: Perspectives for prescribing optimization.
Niels Westergaard et al. Basic Clin Pharmacol Toxicol 2024 - The Value of Pharmacogenomics for White and Indigenous Americans after Kidney Transplantation.
Alexandra Brady et al. Pharmacy (Basel) 2023 11(4) - Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada.
Aneeka Hafeez et al. Pharmacoeconomics 2023 - Warfarin pharmacogenetics in a black Zimbabwean cohort: an observational prospective study.
Marie Madeleine M Hidjo et al. Pharmacogenomics 2023 - A retrospective analysis of preemptive pharmacogenomic testing in 22,918 individuals from China.
Quanfei Huang et al. Journal of clinical laboratory analysis 2023 e24855 - Lack of exposure to pharmacogenomics education among the health care providing students in the West Bank of Palestine.
Yazun Jarrar et al. Drug metabolism and personalized therapy 2023 - Targeted next-generation sequencing of genes involved in Warfarin Pharmacodynamics and pharmacokinetics pathways using the Saudi Warfarin Pharmacogenetic study (SWAP).
Maha Al Ammari et al. The pharmacogenomics journal 2023 - Genome-Wide Association Study Identifies Copy Number Variants Associated with Warfarin Dose Response and Risk of Venous Thromboembolism in African Americans.
Zhang Honghong et al. Clinical pharmacology and therapeutics 2022 - Pharmacogenetics of warfarin and healthcare costs - real-world data analysis.
Lähteenmäki Jaakko et al. Pharmacoepidemiology and drug safety 2022
More
About PGx PHGKB
PGx PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to medications....more
Content Summary
Common PGx Related Topics
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 30, 2024
- Content source: